Lucía Serrano-Marco

The PPARβ/δ Activator GW501516 Prevents the Down-Regulation of AMPK Caused by a High-Fat Diet in Liver and Amplifies the PGC-1α-Lipin 1-PPARα Pathway Leading to Increased Fatty Acid Oxidation

Emma Barroso, Ricardo Rodríguez‐Calvo, Lucía Serrano-Marco et al. · Endocrinology · 2011 · 158 citations · Full text

Fatty Acid Oxidation, High-fat Diet, Fatty Liver Disease +19

Activation of Peroxisome Proliferator–Activated Receptor-β/-δ (PPAR-β/-δ) Ameliorates Insulin Signaling and Reduces SOCS3 Levels by Inhibiting STAT3 in Interleukin-6–Stimulated Adipocytes

Lucía Serrano-Marco, Ricardo Rodríguez‐Calvo, Ilhem El Kochairi et al. · Diabetes · 2011 · 74 citations · Full text

TNF-α inhibits PPARβ/δ activity and SIRT1 expression through NF-κB in human adipocytes

Lucía Serrano-Marco, Matilde R. Chacón, Elsa Maymó‐Masip et al. · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2012 · 51 citations

Inflammation, Metabolic Syndrome, Molecular Physiology +11

Glucose dependence of glycogen synthase activity regulation by GSK3 and MEK/ERK inhibitors and angiotensin-(1–7) action on these pathways in cultured human myotubes

Marta Montori-Grau, Núria Tarrats, Óscar Osorio-Conles et al. · Cellular Signalling · 2013 · 16 citations

Mek/erk Inhibitors, Physiology, Diabetes +10